Arax Advisory Partners’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$837K Buy
29,247
+17,567
+150% +$558K 0.01% 1319
2026
Q1
$368K Buy
11,680
+3,720
+47% +$117K 0.01% 768
2025
Q4
$234K Sell
7,960
-932
-10% -$25.9K 0.01% 966
2025
Q3
$225K Buy
8,892
+8,822
+12,603% +$215K ﹤0.01% 1207
2025
Q2
$1.68K Sell
70
-12
-15% -$278 ﹤0.01% 2624
2025
Q1
$1.88K Buy
+82
New +$1.98K ﹤0.01% 2089
2024
Q4
Sell
-55
Closed -$1.36K 2697
2024
Q3
$1.36K Buy
55
+1
+2% +$30 ﹤0.01% 2165
2024
Q2
$1.61K Hold
54
﹤0.01% 2035
2024
Q1
$1.62K Hold
54
﹤0.01% 1077
2023
Q4
$1.53K Hold
54
﹤0.01% 1060
2023
Q3
$1.99K Buy
54
+1
+2% +$38 ﹤0.01% 1008
2023
Q2
$2.08K Hold
53
﹤0.01% 995
2023
Q1
$1.94K Hold
53
﹤0.01% 997
2022
Q4
$1.63K Buy
+53
New +$1.65K ﹤0.01% 977

Other funds holding RTO

Arax Advisory Partners's RTO Position: Q2 2026 in Review

Arax Advisory Partners increased its Rentokil (RTO) stake by 150% in Q2 2026, buying an estimated $558K and bringing the position to 29,247 shares worth $837K. The position accounts for 0.01% of the portfolio, ranked #1319.

Arax Advisory Partners first reported a position in RTO in Q4 2022 and has held it in 14 quarters since. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Arax Advisory Partners held 29,247 shares of Rentokil worth $837K as of Q2 2026.
  • Arax Advisory Partners bought 17,567 Rentokil shares in Q2 2026, an estimated $558K.
  • Rentokil made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1319 holding.
  • Arax Advisory Partners first reported a position in Rentokil in Q4 2022 and has held it in 14 quarters since.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.